Three Months Ended Nine Months Ended September 30, September 30, (DOLLARS IN THOUSANDS) 2020 2019 2020 2019 Net sales: Taste $ 765,238 $ 782,428 $ 2,343,884 $ 2,398,549 Scent 502,838 484,917 1,470,282 1,457,766 Consolidated $ 1,268,076 $ 1,267,345 $ 3,814,166 $ 3,856,315 Segment profit: Taste $ 101,600 $ 121,425 $ 346,223 $ 383,450 Scent 101,388 87,894 277,156 272,061 Global expenses (9,608) (8,385) (49,550) (35,957) Operational Improvement Initiatives (a)  (712)  (1,652) Frutarom Integration Related Costs (b) (1,883) (10,511) (8,816) (36,825) Restructuring and Other Charges, net (c) (1,497) (3,716) (8,299) (22,415) Losses on sale of assets (415) (372) (1,568) (1,136) FDA Mandated Product Recall (d)  (250)  (250) Frutarom Acquisition Related Costs (e) (808) 2,914 (1,382) (5,182) Compliance Review &amp; Legal Defense Costs (f) (1,000) (3,623) (1,624) (3,623) N&amp;B Transaction Related Costs (g) (8,247)  (24,372)  N&amp;B Integration Related Costs (h) (29,241)  (61,887)  Operating profit 150,289 184,664 465,881 548,471 Interest expense (34,844) (33,497) (99,046) (102,662) Other (expense) income, net (9,945) 5,699 (4,762) 15,114 Income before taxes $ 105,500 $ 156,866 $ 362,073 $ 460,923 _______________________ (a) Represents accelerated depreciation related to a plant relocation in India and China. (b) Represents costs related to the integration of the Frutarom acquisition. For 2020, costs primarily related to advisory services, retention bonuses and performance stock awards. For 2019, costs principally related to advisory services. (c) For 2020, represents costs primarily related to the Frutarom Integration Initiative. For 2019, represents costs primarily related to the Frutarom Integration Initiative and 2019 Severance Program. (d) Represents additional claims that management paid to co-packers. (e) Represents transaction-related costs and expenses related to the acquisition of Frutarom. For 2020, amount primarily includes earn-out payments, net of adjustments, amortization for inventory "step-up" costs and transaction costs principally related to the 2019 Acquisition Activity, including an adjustment to reverse an earnout liability and another adjustment to record an earnout liability in the third quarter of 2020. For 2019, amount primarily includes amortization for inventory "step-up" costs and transaction costs, along with a measurement period adjustment to the amount of the inventory "step-up" recorded. (f) Costs related to reviewing the nature of inappropriate payments and review of compliance in certain other countries. In addition, includes legal costs for related shareholder lawsuits. (g) Represents transaction costs and expenses related to the pending transaction with N&amp;B, principally related to legal and professional fees for capital raising activities. (h) Represents costs primarily related to advisory services for the integration of the pending transaction with N&amp;B, principally consulting fees.